by: David Gutierrez, staff writer (NaturalNews)
Documents unsealed as part of a lawsuit against drug giant Wyeth Pharmaceuticals reveal that the company used ghostwriters to prepare at least 40 medical journal articles promoting the use of its hormone-replacement drug Prempro. Hormone replacement therapy drugs such as Premarin and Prempro were widely popular in the 1990s among women seeking to avoid the symptoms of menopause. The drugs became some of Wyeth’s best sellers, raking in more than $2 billion for the company until a 2002 study showed that they significantly increased women’s risk of invasive breast cancer, heart disease and stroke. Later research also implicated the drugs in an increase dementia risk among the elderly. Use of hormone replacement therapy plummeted, with a corresponding drop in breast cancer rates. Since then, approximately 8,400 lawsuits have been filed against drugmakers Wyeth and Pfizer by more than 10,000 women affected by side effects.
[more...]
Related posts:
- Medical journal papers promoting HRT drugs ghostwritten by major drug company
- Hormone Replacement Therapy and Breast Cancer Link
- Spinning the Spin Part II: Marketing Scientific Research & Studies
- Research Group – Headed by Professor Takashi Tsuji Demonstrates Regenerating “Fully Functional Bioengineered Mature Tooth Unit”
- Law experts speak out – academics who “guest author” medical journal articles guilty of fraud
- New study reveals expensive MRIs pushed on women for breast cancer screening have no medical benefit

